Human papillomavirus vaccination in Auckland: Reducing ethnic and socioeconomic inequities

Vaccine

Volumn 31, Issue 1, 2012, Pages 84-88

  Poole, Tracey ^a   Goodyear Smith, Felicity ^a   Petousis Harris, Helen ^a   Desmond, Natalie ^b   Exeter, Daniel ^a   Pointon, Leah ^a   Jayasinha, Ranmalie ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b AUCKLAND DISTRICT HEALTH BOARD   (New Zealand)

Author keywords

Equity; General practice; Immunisation programme; Papillomavirus vaccines; Schools

Indexed keywords

WART VIRUS VACCINE;

ADOLESCENT; ARTICLE; ETHNICITY; FEMALE; HUMAN; INFORMED CONSENT; MEDICAL RECORD REVIEW; NEW ZEALAND; NORMAL HUMAN; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SOCIOECONOMICS; VACCINATION; VIRUS INFECTION; WART VIRUS;

ADOLESCENT; CHILD; FEMALE; HUMANS; IMMUNIZATION PROGRAMS; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; RETROSPECTIVE STUDIES; VACCINATION;

EID: 84870571466     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.10.099     Document Type: Article

References (14)

1. Ministry of Health Cancer: new registrations and deaths 2008 2011, Ministry of Health, Wellington, June, 127 p.
2. Blakely T., Tobias M., Atkinson J., Yeh L.-C., Huang K. Tracking disparity trends in ethnic and socioeconomic inequalities in mortality, 1981-2004 2007, Ministry of Health, Wellington, 188 p.
3. Population Health Directorate The HPV (Human Papillomavirus) immunisation programme: national implementation strategic overview 2008, Ministry of Health, Wellington, June, 44 p.
4. Brewer N., Borman B., Sarfati D., et al. Does comorbidity explain the ethnic inequalities in cervical cancer survival in New Zealand? A retrospective cohort study. BMC Cancer 2011, 11:132.
5. Cormack D., Purdie G., Robson B. Cancer. Hauora Māori standards of health IV a study of the years 2000-2005 2007, 19-103. Te Ropu Rangahau Hauora a Eru Pomare, University of Otago, Wellington. B.R.R. Harris (Ed.).
6. World Health Organization Immunization, vaccines and biologicals: human papillomavirus (HPV) 2010, World Health Organization, Geneva, [accessed April 2012]. http://www.who.int/immunization/topics/hpv/en/.
7. Anonymous Global measles control and regional elimination, 1998-1999. MMWR - Morb Mortal Wkly Rep 1999, 48(49):1124-1130.
8. Department of Health Annual HPV vaccine uptake in England: 2008/09: routine programme for year 8 girls (12-13 years old) and catch-up campaign for year 13 girls (17-18 years old) 2011, Department of Health, London, January.
9. Watson M., Shaw D., Molchanoff L., McInnes C. Challenges, lessons learned and results following the implementation of a human papilloma virus school vaccination program in South Australia. Aust N Z J Public Health 2009, 33(August (4)):365-370.
10. Immunisation Advisory Centre (IMAC). Immunisation Coverage and Vaccine Preventable Diseases in New Zealand - Periodic Report. Auckland: University of Auckland, 2010. 36 p.
11. Grant C.C., Turner N., Jones R. Eliminating ethnic disparities in health through immunisation: New Zealand's chance to earn global respect. N Z Med J 2009, 122(March (1291)):6-9.
12. Brabin L., Roberts S.A., Stretch R., et al. Uptake of first two doses of human papillomavirus vaccine by adolescent schoolgirls in Manchester: prospective cohort study. BMJ 2008, 336(May (7652)):1056-1058.
13. Roberts S.A., Brabin L., Stretch R., et al. Human papillomavirus vaccination and social inequality: results from a prospective cohort study. Epidemiol Infect 2011, 139(March (3)):400-405.
14. Smith L.M., Brassard P., Kwong J.C., Deeks S.L., Ellis A.K., Levesque L.E. Factors associated with initiation and completion of the quadrivalent human papillomavirus vaccine series in an Ontario cohort of grade 8 girls. BMC Public Health 2011, 11:645.